Lucid Diagnostics Inc. (LUCD)
LUCD Stock Price Chart
Explore Lucid Diagnostics Inc. interactive price chart. Choose custom timeframes to analyze LUCD price movements and trends.
LUCD Company Profile
Discover essential business fundamentals and corporate details for Lucid Diagnostics Inc. (LUCD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
14 Oct 2021
Employees
82.00
Website
https://www.luciddx.comCEO
Lishan Aklog
Description
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
LUCD Financial Timeline
Browse a chronological timeline of Lucid Diagnostics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.04, while revenue estimate is $1.43m.
Earnings released on 14 May 2026
EPS came in at -$0.07 falling short of the estimated -$0.05 by -40.00%, while revenue for the quarter reached $1.26m , missing expectations by -9.00%.
Earnings released on 25 Mar 2026
EPS came in at -$0.10 falling short of the estimated -$0.07 by -42.86%, while revenue for the quarter reached $1.50m , beating expectations by +10.35%.
Earnings released on 12 Nov 2025
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $1.21m , missing expectations by -12.74%.
Earnings released on 13 Aug 2025
EPS came in at -$0.10 falling short of the estimated -$0.09 by -11.11%, while revenue for the quarter reached $1.16m , missing expectations by -32.08%.
Earnings released on 14 May 2025
EPS came in at -$0.16 falling short of the estimated -$0.09 by -77.78%, while revenue for the quarter reached $828.00k , missing expectations by -46.31%.
Earnings released on 24 Mar 2025
EPS came in at -$0.19 falling short of the estimated -$0.15 by -26.67%, while revenue for the quarter reached $1.20m , missing expectations by -4.24%.
Earnings released on 13 Nov 2024
EPS came in at -$0.20 falling short of the estimated -$0.16 by -25.00%, while revenue for the quarter reached $1.17m , missing expectations by -17.72%.
Earnings released on 12 Aug 2024
EPS came in at -$0.20 surpassing the estimated -$0.22 by +9.09%, while revenue for the quarter reached $976.00k , missing expectations by -34.05%.
Earnings released on 13 May 2024
EPS came in at -$0.21 surpassing the estimated -$0.27 by +22.22%, while revenue for the quarter reached $1.00m , missing expectations by -18.62%.
Earnings released on 25 Mar 2024
EPS came in at -$0.23 surpassing the estimated -$0.26 by +11.54%, while revenue for the quarter reached $1.04m , missing expectations by -15.45%.
Earnings released on 13 Nov 2023
EPS came in at -$0.24 surpassing the estimated -$0.27 by +11.11%, while revenue for the quarter reached $783.00k , missing expectations by -29.46%.
Earnings released on 14 Aug 2023
EPS came in at -$0.23 surpassing the estimated -$0.32 by +28.13%, while revenue for the quarter reached $159.00k , missing expectations by -74.35%.
Earnings released on 15 May 2023
EPS came in at -$0.24 surpassing the estimated -$0.35 by +31.43%, while revenue for the quarter reached $446.00k , beating expectations by +86.78%.
Earnings released on 14 Mar 2023
EPS came in at -$0.29 falling short of the estimated $0.38 by -176.32%, while revenue for the quarter reached $112.00k , missing expectations by -81.94%.
Earnings released on 14 Nov 2022
EPS came in at -$0.28 surpassing the estimated -$0.40 by +30.00%, while revenue for the quarter reached $76.00k , missing expectations by -82.38%.
Earnings released on 15 Aug 2022
EPS came in at -$0.28 surpassing the estimated -$0.36 by +22.22%.
Earnings released on 11 May 2022
EPS came in at -$0.23 surpassing the estimated -$0.30 by +23.33%, while revenue for the quarter reached $189.00k , missing expectations by -59.17%.
Earnings released on 28 Mar 2022
EPS came in at -$0.32 falling short of the estimated -$0.20 by -60.00%, while revenue for the quarter reached $300.00k , missing expectations by -23.25%.
Earnings released on 23 Nov 2021
EPS came in at -$0.49 falling short of the estimated -$0.32 by -53.12%, while revenue for the quarter reached $200.00k , meeting expectations.
Earnings released on 14 Oct 2021
EPS came in at -$0.17 .
LUCD Stock Performance
Access detailed LUCD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
